Chimerix Inc

General ticker "CMRX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $159.5M

Chimerix Inc follows the US Stock Market performance with the rate: 14.0%.

Estimated limits based on current volatility of 11.1%: low 2.92$, high 3.24$

Factors to consider:

  • Current price 74.4% above estimated high
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.73$, 1.92$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.98$, 2.33$]

Financial Metrics affecting the CMRX estimates:

  • Negative: Non-GAAP EPS, $ of -0.92 <= 0.10
  • Negative: Operating profit margin, % of -99.65 <= 1.03
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Operating cash flow per share per price, % of -44.76 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term CMRX quotes

Long-term CMRX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $1.98MM $33.82MM $0.32MM
Operating Expenses $175.38MM $94.21MM $93.39MM
Operating Income $-173.40MM $-60.39MM $-93.06MM
Non-Operating Income $0.16MM $232.59MM $10.97MM
Interest Expense $0.00MM $2.92MM $0.00MM
R&D Expense $73.82MM $71.63MM $68.79MM
Income(Loss) $-173.24MM $172.20MM $-82.09MM
Taxes $0.00MM $0.04MM $0.00MM
Profit(Loss) $-173.24MM $172.17MM $-82.09MM
Stockholders Equity $68.25MM $256.86MM $193.03MM
Inventory $2.76MM $0.00MM $0.00MM
Assets $100.54MM $279.34MM $212.77MM
Operating Cash Flow $-99.93MM $-46.87MM $-69.09MM
Capital expenditure $0.21MM $0.07MM $0.09MM
Investing Cash Flow $-44.09MM $70.04MM $70.60MM
Financing Cash Flow $112.43MM $-12.72MM $0.31MM
Earnings Per Share* $-3.01 $1.97 $-0.93

* EPS are Split Adjusted, recent splits may be reflected with a delay.